Author: Milewska, Aleksandra; Nerâ€Kluza, Joanna; Dabrowska, Agnieszka; Bodzonâ€Kulakowska, Anna; Pyrc, Krzysztof; Suder, Piotr
Title: MASS SPECTROMETRY IN VIROLOGICAL SCIENCES Cord-id: ll7bc1li Document date: 2019_12_25
ID: ll7bc1li
Snippet: Virology, as a branch of the life sciences, discovered mass spectrometry (MS) to be the pivotal tool around two decades ago. The technique unveiled the complex network of interactions between the living world of pro†and eukaryotes and viruses, which delivered “a piece of bad news wrapped in protein†as defined by Peter Medawar, Nobel Prize Laureate, in 1960. However, MS is constantly evolving, and novel approaches allow for a better understanding of interactions in this micro†and nanow
Document: Virology, as a branch of the life sciences, discovered mass spectrometry (MS) to be the pivotal tool around two decades ago. The technique unveiled the complex network of interactions between the living world of pro†and eukaryotes and viruses, which delivered “a piece of bad news wrapped in protein†as defined by Peter Medawar, Nobel Prize Laureate, in 1960. However, MS is constantly evolving, and novel approaches allow for a better understanding of interactions in this micro†and nanoworld. Currently, we can investigate the interplay between the virus and the cell by analyzing proteomes, interactomes, virusâ€cell interactions, and search for the compounds that build viral structures. In addition, by using MS, it is possible to look at the cell from the broader perspective and determine the role of viral infection on the scale of the organism, for example, monitoring the crosstalk between infected tissues and the immune system. In such a way, MS became one of the major tools for the modern virology, allowing us to see the infection in the context of the whole cell or the organism. © 2019 Wiley Periodicals, Inc. Mass Spec Rev
Search related documents:
Co phrase search for related documents- active site and additional insight: 1
- active site and lung epithelial cell: 1, 2
- active site and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute sars cov respiratory syndrome coronavirus and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
- acute sars cov respiratory syndrome coronavirus and additional assay: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and additional insight: 1, 2
- acute sars cov respiratory syndrome coronavirus and additional validation: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and adequate treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute sars cov respiratory syndrome coronavirus and living cell: 1
- acute sars cov respiratory syndrome coronavirus and low abundance: 1, 2, 3, 4, 5, 6, 7
- acute sars cov respiratory syndrome coronavirus and low accuracy: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute sars cov respiratory syndrome coronavirus and low expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- acute sars cov respiratory syndrome coronavirus and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- acute sars cov respiratory syndrome coronavirus and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute sars cov respiratory syndrome coronavirus and magnetic bead: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute sars cov respiratory syndrome coronavirus and magnetic nanoparticle: 1
- adaptive immune response and low expression: 1, 2
- adaptive immune response and lung epithelial cell: 1
- adaptive immune response and machine learning: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date